Company / Total Debt
Astria Therapeutics, Inc. Total Debt History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$2.5M
FY2017
5-year range
-
FY2016-FY2017
Trend
-57.1%
vs FY2016
Sector context
#80 of 83
Health Care
What the data says
Among 83 Health Care companies, Astria Therapeutics, Inc. is in the top 4% for total debt.
Based on SEC 10-K filings.
$3M in FY2017.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 83This company $2.5M Sector average $6.2B
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2017, total debt decreased 57.1% year-over-year.
- Ranks #80 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $2.5M | -57.1% |
| FY2016 | $5.8M | - |
| FY2015 | - | - |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026